We are live on ! Find out more
LONA

LeonaBio Inc

105 hedge funds and large institutions have $382M invested in LeonaBio Inc in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $41.5M | Put options by funds: $19.2M

18% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 17

12% more capital invested

Capital invested by funds: $342M → $382M (+$40.2M)

2% more funds holding

Funds holding: 103105 (+2)

0.03% less ownership

Funds ownership: 7.03%7% (-0.03%)

29% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 35

Holders
105
Holders Change
+2
Holders Change %
+1.94%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
25
Reduced
35
Closed
17
Calls
$41.5M
Puts
$19.2M
Net Calls
+$22.3M
Net Calls Change
+$11.1M

LONA Hedge Fund Activity: Q1 2022 in Review

105 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q1 2022, worth a combined $382M — up 12% from $342M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new LONA positions and 17 closed out — a net gain of 3 holders — while 25 added to existing stakes and 35 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $7.31M. The largest seller was Logos Global Management, cutting an estimated $9.63M.

  • 105 institutional investors held LeonaBio Inc (LONA) as of Q1 2022, up from 103 in Q4 2021.
  • Funds reported $382M of LeonaBio Inc stock for Q1 2022, up 12% quarter-over-quarter.
  • 20 funds opened new LeonaBio Inc positions in Q1 2022 and 17 closed out, a net change of +3 holders.
  • The largest LeonaBio Inc buyer in Q1 2022 was Point72 Asset Management, an estimated $7.31M added.
  • The largest LeonaBio Inc seller in Q1 2022 was Logos Global Management, an estimated $9.63M sold.

Based on aggregated 13F filings for Q1 2022.